For the kit and method for the treatment of cancer, including gives gliadin peptide and disclosed with patient. Kit according to the present invention includes a pharmaceutical composition, and it includes the instruction of gliadin peptide, which is administered to patient. The kit can further include pharmaceutical composition, and it includes the instruction co of at least one chemotherapeutant such as receptor tyrosine kinase inhibitors to apply the compound. A kind of gliadin peptide for the treatment of cancer and it is according to the present invention include giving patient and applying at least one chemotherapeutant to may further include such as receptor tyrosine kinase inhibitors. The patient of common gliadin peptide and receptor tyrosine kinase inhibitors carries out effectively being reduced or prevented the anticancer of cancer to receptor tyrosine kinase inhibitors.
